1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Active Pharmaceutical Ingredients Market
5.1 Market Performance
5.2 Market Breakup by Drug Type
5.3 Market Breakup by Manufacturer Type
5.4 Market Breakup by Synthesis Type
5.5 Market Breakup by Therapeutic Application
5.6 Market Breakup by Region
5.7 Market Forecast
6 North America Active Pharmaceutical Ingredients Market
6.1 Market Performance
6.2 Impact of COVID-19
6.3 Market Forecast
7 North America Active Pharmaceutical Ingredients Market: Breakup by Drug Type
7.1 Innovative Active Pharmaceutical Ingredients
7.2 Generic Active Pharmaceutical Ingredients
8 North America Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type
8.1 Captive Manufacturers
8.2 Merchant API Manufacturers
8.2.1 Innovative Merchant API Manufacturers
8.2.2 Generic Merchant API Manufacturers
9 North America Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type
9.1 Synthetic Active Pharmaceutical Ingredients
9.1.1 Innovative Synthetic APIs
9.1.2 Generic Synthetic APIs
9.2 Biotech Active Pharmaceutical Ingredients
9.2.1 Innovative Biotech APIs
9.2.2 Biosimilars
10 North America Biotech Active Pharmaceutical Ingredients Market: Breakup by Product and Expression System Type
10.1 Product Type
10.1.1 Monoclonal Antibodies
10.1.2 Vaccines
10.1.3 Cytokines
10.1.4 Others
10.2 Expression System Type
10.2.1 Mammalian Expression System
10.2.2 Microbial Expression System
10.2.3 Yeast Expression System
10.2.4 Others
11 North America Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application
11.1 Oncology
11.2 Cardiovascular and Respiratory
11.3 Diabetes
11.4 Central Nervous System Disorders
11.5 Neurological Disorders
11.6 Others
12 North America Active Pharmaceutical Ingredients Market: Breakup by Country
12.1 United States
12.1.1 Historical Market Trends
12.1.2 Market Breakup by Drug Type
12.1.3 Market Breakup by Manufacturer Type
12.1.4 Market Breakup by Synthesis Type
12.1.5 Biotech API Market Breakup by Product Type
12.1.6 Biotech API Market Breakup by Expression System Type
12.1.7 Market Breakup by Therapeutic Application
12.1.8 Market Forecast
12.2 Canada
12.2.1 Historical Market Trends
12.2.2 Market Breakup by Drug Type
12.2.3 Market Breakup by Manufacturer Type
12.2.4 Market Breakup by Synthesis Type
12.2.5 Biotech API Market Breakup by Product Type
12.2.6 Biotech API Market Breakup by Expression System Type
12.2.7 Market Breakup by Therapeutic Application
12.2.8 Market Forecast
12.3 Mexico
12.3.1 Historical Market Trends
12.3.2 Market Breakup by Drug Type
12.3.3 Market Breakup by Manufacturer Type
12.3.4 Market Breakup by Synthesis Type
12.3.5 Biotech API Market Breakup by Product Type
12.3.6 Biotech API Market Breakup by Expression System Type
12.3.7 Market Breakup by Therapeutic Application
12.3.8 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porter’s Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Rivalry
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
List of Figures
Figure 1: North America: Active Pharmaceutical Ingredients Market: Major Drivers and Challenges
Figure 2: Global: Active Pharmaceutical Ingredients Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2024
Figure 4: Global: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2024
Figure 5: Global: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2024
Figure 6: Global: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2024
Figure 7: Global: Active Pharmaceutical Ingredients Market: Breakup by Region (in %), 2024
Figure 8: Global: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: North America: Active Pharmaceutical Ingredients Market: Sales Value (in Billion USD), 2019-2024
Figure 10: North America: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 11: North America: Active Pharmaceutical Ingredients Industry: SWOT Analysis
Figure 12: North America: Active Pharmaceutical Ingredients Industry: Value Chain Analysis
Figure 13: North America: Active Pharmaceutical Ingredients Industry: Porter’s Five Forces Analysis
Figure 14: North America: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2024
Figure 15: North America: Active Pharmaceutical Ingredients (Innovative Active Pharmaceutical Ingredients) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 16: North America: Active Pharmaceutical Ingredients (Innovative Active Pharmaceutical Ingredients) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 17: North America: Active Pharmaceutical Ingredients (Generic Active Pharmaceutical Ingredients) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 18: North America: Active Pharmaceutical Ingredients (Generic Active Pharmaceutical Ingredients) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 19: North America: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2024
Figure 20: North America: Active Pharmaceutical Ingredients (Captive Manufacturers) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 21: North America: Active Pharmaceutical Ingredients (Captive Manufacturers) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 22: North America: Active Pharmaceutical Ingredients (Merchant API Manufacturers) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 23: North America: Active Pharmaceutical Ingredients (Merchant API Manufacturers) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 24: North America: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2024
Figure 25: North America: Active Pharmaceutical Ingredients (Synthetic Active Pharmaceutical Ingredients) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 26: North America: Active Pharmaceutical Ingredients (Synthetic Active Pharmaceutical Ingredients) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 27: North America: Active Pharmaceutical Ingredients (Biotech Active Pharmaceutical Ingredients) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 28: North America: Active Pharmaceutical Ingredients (Biotech Active Pharmaceutical Ingredients) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 29: North America: Biotech Active Pharmaceutical Ingredients Market: Breakup by Product Type (in %), 2024
Figure 30: North America: Biotech Active Pharmaceutical Ingredients (Monoclonal Antibodies) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 31: North America: Biotech Active Pharmaceutical Ingredients (Monoclonal Antibodies) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 32: North America: Biotech Active Pharmaceutical Ingredients (Vaccines) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 33: North America: Biotech Active Pharmaceutical Ingredients (Vaccines) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 34: North America: Biotech Active Pharmaceutical Ingredients (Cytokines) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 35: North America: Biotech Active Pharmaceutical Ingredients (Cytokines) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 36: North America: Biotech Active Pharmaceutical Ingredients (Other Product Types) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 37: North America: Biotech Active Pharmaceutical Ingredients (Other Product Types) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 38: North America: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System Type (in %), 2024
Figure 39: North America: Biotech Active Pharmaceutical Ingredients (Mammalian Expression System) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 40: North America: Biotech Active Pharmaceutical Ingredients (Mammalian Expression System) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 41: North America: Biotech Active Pharmaceutical Ingredients (Microbial Expression System) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 42: North America: Biotech Active Pharmaceutical Ingredients (Microbial Expression System) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 43: North America: Biotech Active Pharmaceutical Ingredients (Yeast Expression System) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 44: North America: Biotech Active Pharmaceutical Ingredients (Yeast Expression System) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 45: North America: Biotech Active Pharmaceutical Ingredients (Other Expression System Types) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 46: North America: Biotech Active Pharmaceutical Ingredients (Other Expression System Types) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 47: North America: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2024
Figure 48: North America: Active Pharmaceutical Ingredients (Oncology) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 49: North America: Active Pharmaceutical Ingredients (Oncology) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 50: North America: Active Pharmaceutical Ingredients (Cardiovascular and Respiratory) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 51: North America: Active Pharmaceutical Ingredients (Cardiovascular and Respiratory) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 52: North America: Active Pharmaceutical Ingredients (Diabetes) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 53: North America: Active Pharmaceutical Ingredients (Diabetes) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 54: North America: Active Pharmaceutical Ingredients (Central Nervous System Disorders) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 55: North America: Active Pharmaceutical Ingredients (Central Nervous System Disorders) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 56: North America: Active Pharmaceutical Ingredients (Neurological Disorders) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 57: North America: Active Pharmaceutical Ingredients (Neurological Disorders) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 58: North America: Active Pharmaceutical Ingredients (Other Therapeutic Applications) Market: Sales Value (in Billion USD), 2019 & 2024
Figure 59: North America: Active Pharmaceutical Ingredients (Other Therapeutic Applications) Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 60: United States: Active Pharmaceutical Ingredients Market: Sales Value (in Billion USD), 2019-2024
Figure 61: United States: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2024
Figure 62: United States: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2024
Figure 63: United States: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2024
Figure 64: United States: Biotech Active Pharmaceutical Ingredients Market: Breakup by Product Type (in %), 2024
Figure 65: United States: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System Type (in %), 2024
Figure 66: United States: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2024
Figure 67: United States: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 68: Canada: Active Pharmaceutical Ingredients Market: Sales Value (in Billion USD), 2019-2024
Figure 69: Canada: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2024
Figure 70: Canada: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2024
Figure 71: Canada: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2024
Figure 72: Canada: Biotech Active Pharmaceutical Ingredients Market: Breakup by Product Type (in %), 2024
Figure 73: Canada: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System Type (in %), 2024
Figure 74: Canada: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2024
Figure 75: Canada: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 76: Mexico: Active Pharmaceutical Ingredients Market: Sales Value (in Billion USD), 2019-2024
Figure 77: Mexico: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2024
Figure 78: Mexico: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2024
Figure 79: Mexico: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2024
Figure 80: Mexico: Biotech Active Pharmaceutical Ingredients Market: Breakup by Product Type (in %), 2024
Figure 81: Mexico: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System Type (in %), 2024
Figure 82: Mexico: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2024
Figure 83: Mexico: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion USD), 2025-2033
List of Tables
Table 1: North America: Active Pharmaceutical Ingredients Market: Key Industry Highlights, 2024 and 2033
Table 2: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Drug Type (in Billion USD), 2025-2033
Table 3: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Manufacturer Type (in Billion USD), 2025-2033
Table 4: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Synthesis Type (in Billion USD), 2025-2033
Table 5: North America: Biotech Active Pharmaceutical Ingredients Market Forecast: Breakup by Product Type (in Billion USD), 2025-2033
Table 6: North America: Biotech Active Pharmaceutical Ingredients Market Forecast: Breakup by Expression System Type (in Billion USD), 2025-2033
Table 7: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Therapeutic Application (in Billion USD), 2025-2033
Table 8: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Country (in Billion USD), 2025-2033
Table 9: North America: Active Pharmaceutical Ingredients Market: Competitive Structure
Table 10: North America: Active Pharmaceutical Ingredients Market: Key Players